Annual ROE
-34.78%
-0.12%-0.35%
December 31, 2023
Summary
- As of February 7, 2025, VERV annual return on equity is -34.78%, with the most recent change of -0.12% (-0.35%) on December 31, 2023.
- During the last 3 years, VERV annual ROE has fallen by -106.29% (-148.64%).
- VERV annual ROE is now -135.24% below its all-time high of 98.69%, reached on December 31, 2019.
Performance
VERV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-36.52%
-0.23%-0.63%
September 30, 2024
Summary
- As of February 7, 2025, VERV quarterly return on equity is -36.52%, with the most recent change of -0.23% (-0.63%) on September 30, 2024.
- Over the past year, VERV quarterly ROE has increased by +1.52% (+4.00%).
- VERV quarterly ROE is now -148.02% below its all-time high of 76.05%, reached on March 31, 2021.
Performance
VERV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VERV ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.3% | +4.0% |
| 3 y3 years | -148.6% | +4.0% |
| 5 y5 years | -135.2% | +4.0% |
VERV ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.3% | at low | -0.6% | +18.7% |
| 5 y | 5-year | -135.2% | at low | -148.0% | +67.3% |
| alltime | all time | -135.2% | at low | -148.0% | +67.3% |
Verve Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -36.52%(+0.6%) |
| Jun 2024 | - | -36.29%(-3.5%) |
| Mar 2024 | - | -37.60%(-2.8%) |
| Dec 2023 | -34.78%(+0.3%) | -38.69%(+1.7%) |
| Sep 2023 | - | -38.04%(-6.2%) |
| Jun 2023 | - | -40.56%(+7.8%) |
| Mar 2023 | - | -37.63%(+3.2%) |
| Dec 2022 | -34.66% | -36.46%(-5.3%) |
| Sep 2022 | - | -38.52%(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -36.55%(-1.5%) |
| Mar 2022 | - | -37.11%(-17.4%) |
| Dec 2021 | -33.67%(-147.1%) | -44.92%(-35.1%) |
| Sep 2021 | - | -69.24%(-38.1%) |
| Jun 2021 | - | -111.77%(-247.0%) |
| Mar 2021 | - | 76.05%(+6.3%) |
| Dec 2020 | 71.51%(-27.5%) | - |
| Dec 2020 | - | 71.51% |
| Dec 2019 | 98.69% | - |
FAQ
- What is Verve Therapeutics annual return on equity?
- What is the all time high annual ROE for Verve Therapeutics?
- What is Verve Therapeutics annual ROE year-on-year change?
- What is Verve Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Verve Therapeutics?
- What is Verve Therapeutics quarterly ROE year-on-year change?
What is Verve Therapeutics annual return on equity?
The current annual ROE of VERV is -34.78%
What is the all time high annual ROE for Verve Therapeutics?
Verve Therapeutics all-time high annual return on equity is 98.69%
What is Verve Therapeutics annual ROE year-on-year change?
Over the past year, VERV annual return on equity has changed by -0.12% (-0.35%)
What is Verve Therapeutics quarterly return on equity?
The current quarterly ROE of VERV is -36.52%
What is the all time high quarterly ROE for Verve Therapeutics?
Verve Therapeutics all-time high quarterly return on equity is 76.05%
What is Verve Therapeutics quarterly ROE year-on-year change?
Over the past year, VERV quarterly return on equity has changed by +1.52% (+4.00%)